Tocqueville Asset Management L.P. Has $3.77 Million Stake in AdaptHealth Corp. $AHCO

Key Points

• Tocqueville Asset Management L.P. has reduced its stake in AdaptHealth Corp. by 7.9% during the first quarter, now holding 348,000 shares valued at approximately $3.77 million.
• Several institutional investors have increased their holdings in AdaptHealth, with GAMMA Investing LLC raising its stake by 175.2% in the same quarter.
• AdaptHealth currently has a consensus rating of "Buy" from six research analysts, with an average target price of $13.40.

Tocqueville Asset Management L.P. trimmed its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 7.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 348,000 shares of the company's stock after selling 30,000 shares during the period. Tocqueville Asset Management L.P. owned 0.26% of AdaptHealth worth $3,772,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AHCO. GAMMA Investing LLC boosted its position in AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock valued at $81,000 after buying an additional 4,758 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in AdaptHealth in the first quarter worth about $114,000. Guggenheim Capital LLC increased its stake in shares of AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after purchasing an additional 1,525 shares during the period. Legato Capital Management LLC acquired a new stake in shares of AdaptHealth in the first quarter valued at approximately $167,000. Finally, Humankind Investments LLC increased its stake in shares of AdaptHealth by 18.3% in the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock valued at $171,000 after purchasing an additional 2,776 shares during the period. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Price Performance

NASDAQ:AHCO traded down $0.01 on Thursday, reaching $9.32. The stock had a trading volume of 555,436 shares, compared to its average volume of 1,430,820. AdaptHealth Corp. has a 1-year low of $7.11 and a 1-year high of $11.70. The company has a market capitalization of $1.26 billion, a P/E ratio of 17.26, a price-to-earnings-growth ratio of 1.06 and a beta of 1.58. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.14. The stock has a fifty day moving average price of $9.19 and a 200-day moving average price of $9.26.

Analyst Ratings Changes

AHCO has been the topic of a number of research analyst reports. Royal Bank Of Canada lowered their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research note on Thursday, May 8th. Wall Street Zen raised shares of AdaptHealth from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, Truist Financial decreased their target price on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, May 12th. Five research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.